New York State Common Retirement Fund Portfolio holdings
AUM
$75.2B
1-Year Return
24.38%
This Quarter Return
+7.31%
1 Year Return
+24.38%
3 Year Return
+108.85%
5 Year Return
+192%
10 Year Return
+482.31%
AUM
$90.4B
AUM Growth
+$736M
(+0.82%)
Cap. Flow
-$4.17B
Cap. Flow
% of AUM
-4.61%
Top 10 Holdings %
Top 10 Hldgs %
21.38%
Holding
3,353
New
92
Increased
718
Reduced
1,380
Closed
66
Top Buys
| 1 |
Eli Lilly
LLY
|
+$54.5M |
| 2 |
NXP Semiconductors
NXPI
|
+$42.7M |
| 3 |
Steris
STE
|
+$39.5M |
| 4 |
Expedia Group
EXPE
|
+$37.8M |
| 5 |
ConocoPhillips
COP
|
+$35.7M |
Top Sells
| 1 |
Apple
AAPL
|
+$233M |
| 2 |
JPMorgan Chase
JPM
|
+$114M |
| 3 |
Microsoft
MSFT
|
+$112M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$77.7M |
| 5 |
Charles Schwab
SCHW
|
+$77.1M |
Sector Composition
| 1 | Technology | 24.83% |
| 2 | Healthcare | 14.71% |
| 3 | Financials | 13.91% |
| 4 | Consumer Discretionary | 12.04% |
| 5 | Communication Services | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Orthofix Medical
OFIX
$604M
| $759K | ﹤0.01% |
17,500
+1,200
| +7% | +$52K |
|
2202
Andersons Inc
ANDE
$1.38B
| $758K | ﹤0.01% |
27,700
| – | – |
|
2203
AngioDynamics
ANGO
$436M
| $758K | ﹤0.01% |
32,400
| – | – |
|
2204
Collegium Pharmaceutical
COLL
$1.2B
| $758K | ﹤0.01% |
32,000
| – | – |
|
|
STKL
2205
SunOpta
STKL
$735M
| $758K | ﹤0.01% |
+51,316
| New | +$758K |
|
|
CHUY
2206
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $758K | ﹤0.01% |
17,100
-2,300
| -12% | -$102K |
|
|
FRG
2207
DELISTED
Franchise Group, Inc.
FRG
| $758K | ﹤0.01% |
21,000
+3,400
| +19% | +$123K |
|
|
AMTI
2208
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $757K | ﹤0.01% |
17,200
+5,900
| +52% | +$260K |
|
|
PRSU
2209
Pursuit Attractions and Hospitality, Inc.
PRSU
$1.04B
| $756K | ﹤0.01% |
18,100
| – | – |
|
2210
ProPetro Holding
PUMP
$489M
| $754K | ﹤0.01% |
70,700
| – | – |
|
2211
Columbia Financial
CLBK
$1.61B
| $748K | ﹤0.01% |
42,800
| – | – |
|
2212
Quanex
NX
$674M
| $745K | ﹤0.01% |
28,400
| – | – |
|
2213
Rhythm Pharmaceuticals
RYTM
$6.46B
| $745K | ﹤0.01% |
35,005
+4,000
| +13% | +$85.1K |
|
2214
TruBridge
TBRG
$305M
| $744K | ﹤0.01% |
24,310
| – | – |
|
2215
Univest Financial
UVSP
$889M
| $742K | ﹤0.01% |
25,969
-2,300
| -8% | -$65.7K |
|
2216
1st Source
SRCE
$1.57B
| $740K | ﹤0.01% |
15,560
-9,700
| -38% | -$461K |
|
|
SGFY
2217
DELISTED
Signify Health, Inc.
SGFY
| $740K | ﹤0.01% |
+25,300
| New | +$740K |
|
2218
Perdoceo Education
PRDO
$2.26B
| $739K | ﹤0.01% |
61,800
-271,400
| -81% | -$3.25M |
|
2219
Vishay Precision Group
VPG
$414M
| $738K | ﹤0.01% |
23,956
| – | – |
|
2220
Donnelley Financial Solutions
DFIN
$1.51B
| $737K | ﹤0.01% |
26,500
+2,900
| +12% | +$80.7K |
|
2221
Pliant Therapeutics
PLRX
$97M
| $735K | ﹤0.01% |
18,700
+9,200
| +97% | +$362K |
|
2222
Stoneridge
SRI
$230M
| $735K | ﹤0.01% |
23,100
| – | – |
|
2223
NVE Corp
NVEC
$326M
| $734K | ﹤0.01% |
10,474
| – | – |
|
2224
Keros Therapeutics
KROS
$641M
| $732K | ﹤0.01% |
11,900
+800
| +7% | +$49.2K |
|
2225
Zynex
ZYXI
$45.7M
| $730K | ﹤0.01% |
52,597
+12,251
| +30% | +$170K |
|